Docket Number:12T-1031121
Inventor:Konan Peck, Pan-Chyr Yang, Yi-Chung Chang, Wei-Yun Lai
IP Status:Know-how
Abstract:
Aptamer technology has become one of the hot topics in biotechnology industry. According to M&M (Markets&Markets), a well-known global market research and consulting company, estimated, the global aptamers market was valued at $200 million in the year 2012 and might reach approximately $2.1 billion by 2018.。It can be seen that aptamer technology holds a great potential for pharmaceutical industry. By many years work, we have built up an all-round platform technology that can rapid identify high affinity aptamer againt variable targets.
Fields of Application:
- Identification and development of aptamer drug.
- Aptamer-based ultrasensitive detection technology.
Advantages when compared to the existing technologies:
Aptamer possess a similar function with antibody, however it has several advantages compare to antibody. These advantages included:
- Large scale synthesis
- Chemical production avoid biological contamination
- Often non-immunogenic
- Smaller size allows more efficient entry into biological compartments
- Extremely environmental stable
- Easy to be modified.
Contact Person:Mei-Fang Lee / 886-2-2787-2503 / mflee@gate.sinica.edu.tw
